Skip to main content
Livermore
Livermore
ZHEN

Baker Bros. Advisors LP

SEC CIK
0001263508
Latest filing
Aug 14, 2026

ELVN holding history

Enliven Therapeutics, Inc. in every 13F filed by Baker Bros. Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELVN overviewAll 13F holders of ELVNFull Q2 2026 holdings

Shares (Q2 2026)
905,191
Value
$45.9M
% of portfolio
0.2%
Quarters held
10
Since Q1 2024
Holdings of ELVN by Baker Bros. Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026905,191$45.9M0.2%00.0%UnchangedHolders
Q1 2026905,191$35.5M0.2%+633,785+233.5%AddedHolders
Q4 2025271,406$4.18M<0.1%+156,573+136.3%AddedHolders
Q3 2025114,833$2.35M<0.1%00.0%UnchangedHolders
Q2 2025114,833$2.30M<0.1%00.0%UnchangedHolders
Q1 2025114,833$2.26M<0.1%00.0%UnchangedHolders
Q4 2024114,833$2.58M<0.1%00.0%UnchangedHolders
Q3 2024114,833$2.93M<0.1%00.0%UnchangedHolders
Q2 2024114,833$2.68M<0.1%00.0%UnchangedHolders
Q1 2024114,833$2.02M<0.1%+114,833NewHolders